Delosa, Ayesha Mae M.
HRN: 21-40-08 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/21/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
05/21/2022
05/28/2022
IV
46mg
OD
AGE With Mod DHN, BFS, PCAP B
Waiting Final Action
Indication: Empiric Type of Infection: PneumoniaIntra-abdominalCentral Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes